Back
Day Range
$18.91
$19.50
52-Week Range
$17.86
$29.62
Volume
443,257
50D / 200D Avg
$22.25
/
$24.03
Prev Close
$18.85
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -76.3 | 0.4 |
| P/B | 2.5 | 2.9 |
| ROE % | -3.4 | 3.8 |
| Net Margin % | -12.6 | 3.9 |
| Rev Growth 5Y % | -5.2 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$33.00
+72.1%
Low: $32.00
High: $34.00
Forward P/E
129.7
Forward EPS
$0.15
EPS Growth (est.)
+0.0%
Est. Revenue
110 M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.81
$1.77 – $1.85
|
240 M | 1 |
| FY2029 |
$1.31
$1.28 – $1.34
|
200 M | 1 |
| FY2028 |
$0.88
$0.86 – $0.90
|
170 M | 1 |
Key Takeaways
Revenue declined -5.21% annually over 5 years
Debt/Equity of 0.05 — conservative balance sheet
Generating 10.64M in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 22.18%
Capital efficient — spends only 9.85% of revenue on capex
Growth
Revenue Growth (5Y)
-5.21%
Revenue (1Y)16.97%
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-3.37%
ROIC-2.33%
Net Margin-12.61%
Op. Margin-12.61%
Safety
Debt / Equity
0.05
Current Ratio5.23
Interest Coverage-4.48
Valuation
P/E Ratio
-76.33
P/B Ratio2.49
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 16.97% | Revenue Growth (3Y) | 12.62% |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | -5.21% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 96.21M | Net Income (TTM) | -12.13M |
| ROE | -3.37% | ROA | -2.99% |
| Gross Margin | 64.56% | Operating Margin | -12.61% |
| Net Margin | -12.61% | Free Cash Flow (TTM) | 10.64M |
| ROIC | -2.33% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.05 | Current Ratio | 5.23 |
| Interest Coverage | -4.48 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -76.33 | P/B Ratio | 2.49 |
| P/S Ratio | 9.62 | PEG Ratio | 2.20 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 925.91M | Enterprise Value | 910.77M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 96.21M | 82.25M | 75.86M | 76.24M | 119.16M |
| Net Income | -12.13M | -20.18M | -66.43M | -139.81M | -8.91M |
| EPS (Diluted) | -0.25 | -0.44 | -1.52 | -3.29 | -0.23 |
| Gross Profit | 62.12M | 53.67M | 46.75M | 46.91M | 28.85M |
| Operating Income | -12.13M | -7.13M | -23.44M | -5.92M | -35.16M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 405.88M | 399.49M | 412.71M | 450.23M | 552.60M |
| Total Liabilities | 34.00M | 50.58M | 75.05M | 86.04M | 76.24M |
| Shareholders' Equity | 371.89M | 348.91M | 337.66M | 364.19M | 480.75M |
| Total Debt | 17.90M | 30.17M | 33.83M | 43.71M | 26.88M |
| Cash & Equivalents | 33.04M | 95.39M | 27.90M | 19.44M | 69.87M |
| Current Assets | 120.18M | 148.76M | 120.60M | 138.45M | 125.86M |
| Current Liabilities | 22.98M | 32.73M | 42.18M | 44.58M | 42.70M |